Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:00
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:55
Asia Markets Under Pressure After Treasuries Slip : Markets Wrap
Shares in Asia fell after Jerome Powell warned interest rates may have to climb further, stunting a rally
2023-11-10 09:15
Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:57
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
2023-07-28 14:45
European Stocks Muted After First-Half Gains; Energy Shares Rise
European stocks were muted on Monday following gains in the first half of the year as cyclical sectors
2023-07-03 21:28
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
2023-07-03 14:47
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:22
Sanofi Cuts Zantac Risk With Arbitration Win Over Boehringer
Sanofi defeated Boehringer Ingelheim GmbH in an arbitration proceeding over legal responsibilities tied to controversial heartburn medicine Zantac.
2023-06-20 15:22
Pan-African Approach Needed to Ensure Food Security: New Economy
A pan-African approach is needed to solve the continent’s food-security dilemma given the high cost of developing agricultural
2023-06-14 23:16
Britain’s Post-Brexit Policy Drift Alarms World’s Executives
When Dan Vahdat set out to build a healthcare startup, the UK was an ideal launchpad. That was
2023-06-12 07:28
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
2023-06-09 15:29